CN1302796C - Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method - Google Patents
Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method Download PDFInfo
- Publication number
- CN1302796C CN1302796C CNB2004100245221A CN200410024522A CN1302796C CN 1302796 C CN1302796 C CN 1302796C CN B2004100245221 A CNB2004100245221 A CN B2004100245221A CN 200410024522 A CN200410024522 A CN 200410024522A CN 1302796 C CN1302796 C CN 1302796C
- Authority
- CN
- China
- Prior art keywords
- radix
- semen
- traditional chinese
- filtrate
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 28
- 241000287828 Gallus gallus Species 0.000 claims abstract description 9
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000006188 syrup Substances 0.000 claims abstract description 7
- 235000020357 syrup Nutrition 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 239000006187 pill Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 36
- 239000000706 filtrate Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- -1 filtered Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 241000005787 Cistanche Species 0.000 claims description 8
- 241000190633 Cordyceps Species 0.000 claims description 8
- 244000268590 Euryale ferox Species 0.000 claims description 8
- 235000006487 Euryale ferox Nutrition 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 210000003038 endothelium Anatomy 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 240000001008 Dimocarpus longan Species 0.000 claims description 6
- 235000000235 Euphoria longan Nutrition 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 210000000078 claw Anatomy 0.000 claims description 2
- 210000003746 feather Anatomy 0.000 claims description 2
- 210000000936 intestine Anatomy 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 1
- 229960001375 lactose Drugs 0.000 claims 1
- 229940057948 magnesium stearate Drugs 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 238000002512 chemotherapy Methods 0.000 abstract description 9
- 201000002364 leukopenia Diseases 0.000 abstract description 8
- 231100001022 leukopenia Toxicity 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract 2
- 241000133134 Saussurea Species 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 13
- 238000012545 processing Methods 0.000 description 10
- 206010016256 fatigue Diseases 0.000 description 8
- 206010003549 asthenia Diseases 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 108010052008 colla corii asini Proteins 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010024419 Libido decreased Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to traditional Chinese medicament for treating women sub-health exhaustion syndrome. The present invention is characterized in that the traditional Chinese medicament is prepared from 30 kinds of traditional Chinese medicine such as black-bone chicken, saussurea eriocephala, ganoderma, aweto, etc. The traditional Chinese medicament has preparations such as granular preparations, capsule preparations, tablets, oral liquid, syrup, turbid suspending preparations, dripping pills aned the like, and has the functions for nourishing Yin, removing impatency, benefiting qi, nourishing blood, strengthening brain, tranquilizing, relaxing bowels, promoting beautification and strengthening bodies. When used for clinically treating 137 cases of patients of Chinese medicine consumptive disease deficiency of qi and blood, the traditional Chinese medicament has the total effective rate of 95.6%. When used for treating leukopenia caused by radiotherapy and chemotherapy, the traditional Chinese medicament has the total effective rate of 93.3%.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparation, especially treat Chinese medicine preparation of women's subhealth state fatigue syndrome and preparation method thereof, its dosage form comprises tablet, capsule, oral liquid, syrup, drop pill, belongs to field of traditional Chinese.
Background technology:
Women's fatigue syndrome (subhealth state) is women's common clinical card, belong to traditional Chinese medical science asthenia insufficiency of vital energy and blood card, mainly contain god decline body tired, have a dizzy spell, symptom such as soreness of the waist and knees, hyposexuality, shortness of breath and palpitation, forgetful insomnia, inappetence, menoxenia, health are thin and weak.With the quickening pace of modern life, the increase of professional women's life and work pressure is in state tired out for a long time, occurs above-mentioned symptom easily, brings out so easily for a long time or increases the weight of multiple disease.The most physical weakness of patient behind women puerperal, postoperative and the chemicotherapy also needs benefiting qi and nourishing blood with the enhancing immunity fast track rehabilitation in addition.
The present invention belongs to women's fatigue syndrome (subhealth state) of deficiency of both YIN and YANG, deficiency of both QI and blood just at card.The present invention has the effect of Yin-nourishing and Yang-supporting, benefiting qi and nourishing blood, invigorating brain and relieving mental uneasiness, relieving constipation skin care, building body.Cure mainly god decline body tired, have a dizzy spell, disease such as soreness of the waist and knees, hyposexuality, shortness of breath and palpitation, forgetful insomnia, constipation, inappetence, menoxenia, health are thin and weak, also can be used for the rehabilitation maintenance after puerperal, postoperative, the chemotherapy.By clinical observation, the present invention reaches 95.6% to asthenia insufficiency of vital energy and blood card patient's clinical total effective rate, and the leukopenia total effective rate of putting, cause after the chemotherapy is reached 93.3%, and the present invention can improve the human body cell immune function in addition, and do not find tangible untoward reaction, clinical effectiveness is satisfied.At present, clinically to evident in efficacy, safety good, Chinese medicine preparation easy to use is still for being badly in need of.By after the present invention and the existing similar medicine contrast, we think that curative effect of the present invention is reliable, and have one's own knack on prescription medicine, are the crystallizations of clinical experience for many years.Therefore exploitation of the present invention is expected to become a clinical safety, the desirable Chinese medicine preparation effective, cheap, easy to use of providing, and is expected to obtain better economic, social benefit after applying.
Summary of the invention:
The invention belongs to a kind of Chinese medicine preparation of the women's of treatment subhealth state fatigue syndrome.It is characterized in that by Yin-nourishing and Yang-supporting, the Chinese prescription of benefiting qi and nourishing blood forms, and comprises Gallus Domesticus (removing feather claw and intestine) 10～50%, Herba Saussureae Involueratae 0.1～2%, Ganoderma 1～10%, Cordyceps 0.1～4%, Herba Epimedii 1～10%, Semen Juglandis 0.5～5%, Herba Cistanches 0.5～5%, Radix Et Caulis Acanthopanacis Senticosi 0.5～10%, Semen Ziziphi Spinosae 0.5～5%, Radix Asparagi 0.1～8%, Fructus Lycii 0.5～10%, Bulbus Lilii 0.4～4%, the Radix Astragali 1～10%, Rhizoma Dioscoreae 0.4～8%, Poria 0.5～10%, Semen Coicis 0.4～4%, Radix Polygoni Multiflori 0.5～10%, Radix Rehmanniae Preparata 0.5～10%, Radix Angelicae Sinensis 0.4～4%, Radix Salviae Miltiorrhizae 0.5～10%, Arillus Longan 0.2～4%, Semen Nelumbinis 0.2～4%, Semen Euryales 0.2～4%, Fructus Rosae Laevigatae 0.2～4%, Fructus Crataegi 0.5～10%, Endothelium Corneum Gigeriae Galli 0.5～10%, Pericarpium Citri Reticulatae 1～10%, Fructus Jujubae 1～10%, Radix Glycyrrhizae 1～10%, Mel 10～40%.
Technical scheme of the present invention is: get Gallus Domesticus, pulverize, decoct with water twice, each 2 hours, merge extractive liquid, filtered, and filtrate adds hydrochloric acid and transfers pH value to 4～5, and cold preservation 12 hours filters filtrate for later use; Get Herba Saussureae Involueratae again, Ganoderma, Cordyceps, Herba Epimedii, Semen Juglandis, Herba Cistanches, Radix Et Caulis Acanthopanacis Senticosi, Semen Ziziphi Spinosae, Radix Asparagi, Fructus Lycii, Bulbus Lilii, the Radix Astragali (processing), Rhizoma Dioscoreae, Poria, Semen Coicis, Radix Polygoni Multiflori (system), Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Arillus Longan, Semen Nelumbinis, Semen Euryales, Fructus Rosae Laevigatae, Fructus Crataegi, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Fructus Jujubae, Radix Glycyrrhizae (processing) 28 flavors, decoct with water twice, each 2 hours, merge extractive liquid,, filter, filtrate and above-mentioned filtrate merge, be condensed into relative density and be 1.22～1.26 thick paste, add Mel, mixing, available distinct methods drying is pulverized, and is the dried medicated powder of extraction of the present invention; Or to get relative density that above-mentioned mixed liquor is concentrated into about 500ml be 1.04～1.08 concentrated solution, and cold putting 24 hours filters, and adds an amount of distilled water, adds Mel, mixing, and filtrate is the present invention and extracts medicinal liquid.The different auxiliary material that adds in the different dosage form of the present invention does not influence clinical effectiveness of the present invention, and these adjuvants comprise starch, little product cellulose, magnesium stearate, dextrin, lactose, sucrose, antiseptic, Polyethylene Glycol etc.Therefore the present invention can satisfy the requirement of numerous women's fatigue syndrome (subhealth state) patient to different dosage form.
The Chinese medicine preparation that the purpose of this invention is to provide a kind of treatment women's fatigue syndrome (subhealth state) with obvious curative effects.The Pharmacodynamic test of active extract result of this preparation shows: this preparation can obviously increase the weight of mouse immune organ thymus, and the certain increase mouse spleen weight and the trend of K value are arranged, and points out it that effect that increases the body nonspecific immunity is arranged; This preparation can obviously prolong the low temperature swimming time of mice, shows that it has cold-resistant preferably and antifatigue effect; This preparation energy significant prolongation mice hypoxia endurance time; This preparation can significantly raise, and WBC that CTX causes mice reduces and neutrophil reduces.Acute toxicity test of the present invention and long term toxicity test result show and do not see overt toxicity reaction.
Compare clinically with oral liquid treatment traditional Chinese medical science asthenia insufficiency of vital energy and blood card patient 137 examples of the present invention, and with ZHONGHUA WUJI JING.The result shows test group obvious effective rate 62.0%, total effective rate 95.6%, and matched group obvious effective rate 39.7%, and total effective rate 85.3, both have compared significant difference (P＜0.05), show that this preparation is evident in efficacy to traditional Chinese medical science asthenia insufficiency of vital energy and blood card.Clinical in addition this preparation for treating of usefulness by put, leukopenia caused by cancer chemotherapy disease, and compare with FUFANG EJIAO JIANG.The result shows: test group obvious effective rate 46.7%, and total effective rate 93.3%, and matched group obvious effective rate 46.7%, total effective rate 90%, both compare there was no significant difference (P＞0.05).Show this product to by put, leukopenia caused by cancer chemotherapy disease also has curative effect preferably.In the clinical trial process, do not find that this preparation has obvious toxicity, illustrate that the present invention takes safety.
Traditional Chinese medical science efficacy analysis of the present invention:
1 materials and methods
1.1 outpatient's 235 examples are observed in this clinical trial of physical data altogether, inpatient's 30 examples, Attached Hospital of Shandong College of Traditional Chinese Medicine's 144 examples wherein, Hospital Affiliated to Shandong Medical College's 60 examples, the hospital of traditional Chinese hospital, area, Heze 61 examples.All be divided into treatment group and matched group at random.Test group 137 examples are wherein tested I and are organized 137 examples, wherein male 56 examples, women 81 examples, 43.29 ± 12.90 years old mean age; Test II organizes 30 examples, wherein male 17 examples, women 13 examples, 42.13 ± 13.02 years old mean age; Matched group 98 examples, contrast I organizes 68 examples, wherein male 31 examples, women 37 examples, mean age 44.10 ± l3.26 year; Contrast II organizes 30 examples, wherein male 16 examples, women 14 examples, 42.23 ± 13.15 years old mean age.Two groups are not had significant difference in sex, age distribution.Two groups of patient's diseases are evenly distributed in addition, and no significant difference has comparability.
1.2 Therapeutic Method test group oral liquid of the present invention, each 1 (10ml), every day 2 times.Contrast I group is taken ZHONGHUA WUJI JING (being produced by Beijing wujijing factory), and is oral, each 1 (10ml), every day 2 times; Contrast II group is taken FUFANG EJIAO JIANG (being produced by Donga, Shandong Colla Corii Asini Group Plc), and is oral, each 1 (20ml), every day 2 times.Two groups was 1 course of treatment with 1 month all, finished back statistics curative effect 1 course of treatment.
1.3 observation item observe two groups before and after the treatment spiritlessness and weakness, insomnia and dreamful sleep, forgetful, shortness of breath and palpitation, have a dizzy spell, soreness of the waist and knees, numb limbs and tense tendons, inappetence, spontaneous perspiration, 10 symptoms performances of sexual hypofunction.
1.4 efficacy assessment standard comprehensive therapeutic effect evaluation criteria: with reference to " Chinese medicine (new drug) treatment senile disease clinical research guideline "; Leukopenia efficacy assessment standard: evaluate with reference to " hematopathy curative effect and diagnostic criteria ".
1.5 statistical procedures adopts Ridit to analyze and the t check is carried out statistical procedures to related data.
2 results
Clinical comprehensive therapeutic effect: see Table 1～2
Table 1 pair traditional Chinese medical science asthenia insufficiency of vital energy and blood card curative effect relatively
| Group | The example number | Produce effects | Effectively | Invalid | Obvious effective rate | Total effective rate |
| The test group matched group | 137 68 | 85 27 | 46 31 | 6 10 | 62.0％ 39.7％ | 95.6％ 85.3％ |
Analyze through Ridit, P＜0.05, test group is better than matched group.
Table 2 pair by put, leukopenia caused by cancer chemotherapy disease curative effect relatively
| Group | The example number | Produce effects | Effectively | Invalid | Obvious effective rate | Total effective rate |
| The test group matched group | 30 30 | 12 13 | 16 14 | 2 3 | 40％ 43.3％ | 93.3％ 90％ |
Analyze through Ridit, P＞0.05, test group and matched group do not have significant difference.
By table 1～2 as can be known, test group reaches 95.6% to 137 routine traditional Chinese medical science asthenia insufficiency of vital energy and blood card patients' treatment total effective rate, is better than matched group, and two groups of curative effects are compared process Ridit analysis significant difference (P＜0.05); Test group to put, the treatment of leukopenia caused by cancer chemotherapy disease, total effective rate reaches 93.3%, compares there was no significant difference with matched group.Show the present invention for traditional Chinese medical science asthenia insufficiency of vital energy and blood card sufferer and put, the treatment of leukopenia caused by cancer chemotherapy disease all has curative effect preferably.Find in the clinical trial process that in addition the present invention is particularly remarkable to the curative effect of female patient.
Prescription of the present invention also can add the Chinese medicine that other have Yin-nourishing and Yang-supporting, benefiting qi and nourishing blood on the basis of above-mentioned 30 flavor medicines.
Using method of the present invention: oral, every day 2 times.Each 1～2 (or 10～20ml syrup, or 10～15 of drop pill, or 2～4 capsules, or 2～4 tablets of tablets, or one bag of granule).One month is a course of treatment.
The specific embodiment:
Embodiment 1:
Get Gallus Domesticus 200g, pulverize, decoct with water twice, each 2 hours, merge extractive liquid, filtered, and filtrate adds hydrochloric acid and transfers pH value to 4～5, and cold preservation 12 hours filters filtrate for later use; Get Herba Saussureae Involueratae 2g again, Ganoderma 20g, Cordyceps 2g, Herba Epimedii 10g, Semen Juglandis 4g, Herba Cistanches 8g, Radix Et Caulis Acanthopanacis Senticosi 8g, Semen Ziziphi Spinosae 6g, Radix Asparagi 5g, Fructus Lycii 10g, Bulbus Lilii 5g, the Radix Astragali (processing) 12g, Rhizoma Dioscoreae 8g, Poria 8g, Semen Coicis 5g, Radix Polygoni Multiflori (system) 8g, Radix Rehmanniae Preparata 10g, Radix Angelicae Sinensis 6g, Radix Salviae Miltiorrhizae 8g, Arillus Longan 4g, Semen Nelumbinis 8g, Semen Euryales 6g, Fructus Rosae Laevigatae 6g, Fructus Crataegi 16g, Endothelium Corneum Gigeriae Galli 12g, Pericarpium Citri Reticulatae 15g, Fructus Jujubae 12g, Radix Glycyrrhizae (processing) 15g, decoct with water twice, each 2 hours, merge extractive liquid,, filter, filtrate and above-mentioned filtrate merge, being condensed into relative density is the thick paste of 1.22～1.24 (60 ℃), add Mel 50g, mixing, dry, pulverize, be the dried medicated powder of extraction of the present invention; Or get above-mentioned mixed liquor and be concentrated into about 500ml (relative density is 1.04～1.08,60 ℃), cold putting (2～2 ℃) 24 hours filters, and adds Mel 50g, mixing, and filtrate is the present invention and extracts medicinal liquid.
Embodiment 2:
Get Gallus Domesticus 60g, pulverize, decoct with water twice, each 2 hours, merge extractive liquid, filtered, and filtrate adds hydrochloric acid and transfers pH value to 4～5, and cold preservation 12 hours filters filtrate for later use; Get Herba Saussureae Involueratae 1g again, Ganoderma 10g, Cordyceps 1g, Herba Epimedii 6g, Semen Juglandis 8g, Herba Cistanches 4g, Radix Et Caulis Acanthopanacis Senticosi 10g, Semen Ziziphi Spinosae 8g, Radix Asparagi 3g, Fructus Lycii 12g, Bulbus Lilii 5g, the Radix Astragali (processing) 6g, Rhizoma Dioscoreae 4g, Poria 10g, Semen Coicis 8g, Radix Polygoni Multiflori (system) 6g, Radix Rehmanniae Preparata 12g, Radix Angelicae Sinensis 4g, Radix Salviae Miltiorrhizae 10g, Arillus Longan 2g, Semen Nelumbinis 3g, Semen Euryales 3g, Fructus Rosae Laevigatae 3g, Fructus Crataegi 6g, Endothelium Corneum Gigeriae Galli 4g, Pericarpium Citri Reticulatae 5g, Fructus Jujubae 8g, Radix Glycyrrhizae (processing) 8g, decoct with water twice, each 2 hours, merge extractive liquid,, filter, filtrate and above-mentioned filtrate merge, being condensed into relative density is the thick paste of 1.24～1.26 (60 ℃), add Mel 80g, mixing, drying under reduced pressure, pulverize, be the dried medicated powder of extraction of the present invention; Or get above-mentioned mixed liquor and be concentrated into about 500ml (relative density is 1.04～1.08,60 ℃), cold putting (2～2 ℃) 24 hours filters, and adds Mel 80g, mixing, and filtrate is the present invention and extracts medicinal liquid.
Embodiment 3:
Get Gallus Domesticus 120g, pulverize, decoct with water twice, each 2 hours, merge extractive liquid, filtered, and filtrate adds hydrochloric acid and transfers pH value to 4～5, and cold preservation 12 hours filters filtrate for later use; Get Herba Saussureae Involueratae 1g again, Ganoderma 16g, Cordyceps 1g, Herba Epimedii 12g, Semen Juglandis 8g, Herba Cistanches 3g, Radix Et Caulis Acanthopanacis Senticosi 4g, Semen Ziziphi Spinosae 3g, Radix Asparagi 4g, Fructus Lycii 4g, Bulbus Lilii 3g, the Radix Astragali (processing) 8g, Rhizoma Dioscoreae 10g, Poria 10g, Semen Coicis 3g, Radix Polygoni Multiflori (system) 6g, Radix Rehmanniae Preparata 6g, Radix Angelicae Sinensis 10g, Radix Salviae Miltiorrhizae 6g, Arillus Longan 6g, Semen Nelumbinis 6g, Semen Euryales 5g, Fructus Rosae Laevigatae 3g, Fructus Crataegi 10g, Endothelium Corneum Gigeriae Galli 10g, Pericarpium Citri Reticulatae 12g, Fructus Jujubae 5g, Radix Glycyrrhizae (processing) 12g, decoct with water twice, each 2 hours, merge extractive liquid,, filter, filtrate and above-mentioned filtrate merge, being condensed into relative density is the thick paste of 1.22～1.24 (60 ℃), add Mel 40g, mixing, spray drying, pulverize, be the dried medicated powder of extraction of the present invention; Or get above-mentioned mixed liquor and be concentrated into about 500ml (relative density is 1.04～1.08,60 ℃), cold putting (2～2 ℃) 24 hours filters, and adds Mel 40g, mixing, and filtrate is the present invention and extracts medicinal liquid.
Embodiment 4:
Get Gallus Domesticus 150g, pulverize, decoct with water twice, each 2 hours, merge extractive liquid, filtered, and filtrate adds hydrochloric acid and transfers pH value to 4～5, and cold preservation 12 hours filters filtrate for later use; Get Herba Saussureae Involueratae 0.5g again, Ganoderma 25g, Cordyceps 1.5g, Herba Epimedii 6g, Semen Juglandis 8g, Herba Cistanches 8g, Radix Et Caulis Acanthopanacis Senticosi 6g, Semen Ziziphi Spinosae 8g, Radix Asparagi 6g, Fructus Lycii 6g, Bulbus Lilii 5g, the Radix Astragali (processing) 8g, Rhizoma Dioscoreae 8g, Poria 16g, Semen Coicis 6g, Radix Polygoni Multiflori (system) 10g, Radix Rehmanniae Preparata 10g, Radix Angelicae Sinensis 10g, Radix Salviae Miltiorrhizae 10g, Arillus Longan 2g, Semen Nelumbinis 2g, Semen Euryales 2g, Fructus Rosae Laevigatae 5g, Fructus Crataegi 6g, Endothelium Corneum Gigeriae Galli 6g, Pericarpium Citri Reticulatae 12g, Fructus Jujubae 12g, Radix Glycyrrhizae (processing) 8g, decoct with water twice, each 2 hours, merge extractive liquid,, filter, filtrate and above-mentioned filtrate merge, being condensed into relative density is the thick paste of 1.24～1.26 (60 ℃), add Mel 60g, mixing, dry, pulverize, be the dried medicated powder of extraction of the present invention; Or get above-mentioned mixed liquor and be concentrated into about 500ml (relative density is 1.04～1.08,60 ℃), cold putting (2～2 ℃) 24 hours filters, and adds Mel 60g, mixing, and filtrate is the present invention and extracts medicinal liquid.
Embodiment 5: syrup
With any one extracting and to add 0.3% sodium benzoate in the medicinal liquid in the foregoing description, add sucrose 300g, xanthan gum 100g makes the 1000ml syrup, syrup of the present invention.
Embodiment 6: oral liquid
To any one extract and to add 0.3% sodium benzoate in the medicinal liquid in the foregoing description, the 400ml distilled water, sterilization, the 1000ml oral liquid is made in fill, oral liquid of the present invention.
Embodiment 7: granule
Will be in the foregoing description any one extracts and adds lactose 200g in the dried medicated powder, and dextrin 600g granulates, and granulate sieves, and makes the 1000g granule, granule of the present invention.
Embodiment 8: granule
Will be in the foregoing description any one extracts and adds starch 125g in the dried medicated powder, mixes, and granulates, and sieves, and adorns 1000 capsules, capsule of the present invention.
Embodiment 9: tablet
Will be in the foregoing description any one extracts and adds 130g starch in the dried medicated powder, and mixing is granulated, and oven dry is sieved, and adds the 20g microcrystalline Cellulose, the 2g magnesium stearate, mixing is pressed into 1000, tablet of the present invention.
Embodiment 10: drop pill
Be heated among fused Polyethylene Glycol-6000800g any one extracting in the dried medicated powder in the foregoing description, adding, stirring and dissolving is dripped and is made 1000 balls, drop pill of the present invention.
According to prescription of the present invention, can also make the preparation of other dosage forms such as muddy outstanding agent.
Claims (3)
1. a Chinese medicine preparation for the treatment of women's subhealth state fatigue syndrome is characterized in that the raw material of making effective ingredient consists of: removing feather claw and intestine Gallus Domesticus 10～50%, Herba Saussureae Involueratae 0.1～2%, Ganoderma 1～10%, Cordyceps 0.1～4%, Herba Epimedii 1～10%, Semen Juglandis 0.5～5%, Herba Cistanches 0.5～5%, Radix Et Caulis Acanthopanacis Senticosi 0.5～10%, Semen Ziziphi Spinosae 0.5～5%, Radix Asparagi 0.1～8%, Fructus Lycii 0.5～10%, Bulbus Lilii 0.4～4%, the Radix Astragali 1～10%, Rhizoma Dioscoreae 0.4～8%, Poria 0.5～10%, Semen Coicis 0.4～4%, Radix Polygoni Multiflori 0.5～10%, Radix Rehmanniae Preparata 0.5～10%, Radix Angelicae Sinensis 0.4～4%, Radix Salviae Miltiorrhizae 0.5～10%, Arillus Longan 0.2～4%, Semen Nelumbinis 0.2～4%, Semen Euryales 0.2～4%, Fructus Rosae Laevigatae 0.2～4%, Fructus Crataegi 0.5～10%, Endothelium Corneum Gigeriae Galli 0.5～10%, Pericarpium Citri Reticulatae 1～10%, Fructus Jujubae 1～10%, Radix Glycyrrhizae 1～10%, Mel 10～40%.
2. the preparation method of the described Chinese medicine preparation of claim 1 is characterized in that the technological process of described preparation is: get Gallus Domesticus, pulverize, decoct with water twice, each 2 hours, merge extractive liquid, filtered, and filtrate adds hydrochloric acid and transfers pH value to 4～5, cold preservation 12 hours filters filtrate for later use; Get Herba Saussureae Involueratae again, Ganoderma, Cordyceps, Herba Epimedii, Semen Juglandis, Herba Cistanches, Radix Et Caulis Acanthopanacis Senticosi, Semen Ziziphi Spinosae, Radix Asparagi, Fructus Lycii, Bulbus Lilii, the Radix Astragali, Rhizoma Dioscoreae, Poria, Semen Coicis, Radix Polygoni Multiflori, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Arillus Longan, Semen Nelumbinis, Semen Euryales, Fructus Rosae Laevigatae, Fructus Crataegi, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae, Fructus Jujubae, Radix Glycyrrhizae 28 flavors, decoct with water twice, each 2 hours, merge extractive liquid,, filter, filtrate and above-mentioned filtrate merge, be condensed into relative density and be 1.22～1.26 thick paste, add Mel, mixing, available distinct methods drying is pulverized, and is the dried medicated powder of extraction of the present invention; Or to get relative density that above-mentioned mixed liquor is concentrated into about 500ml be 1.04～1.08 concentrated solution, and cold putting 24 hours filters, and adds an amount of distilled water, adds Mel, mixing, and filtrate is the present invention and extracts medicinal liquid.
3. the described Chinese medicine preparation of claim 1, it is characterized in that by adding following adjuvant: starch, dextrin, microcrystalline Cellulose, magnesium stearate, lactose, sucrose, xanthan gum, Polyethylene Glycol, can be made into granule, capsule, tablet, oral liquid, syrup, muddy outstanding agent, drop pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100245221A CN1302796C (en) | 2004-07-26 | 2004-07-26 | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100245221A CN1302796C (en) | 2004-07-26 | 2004-07-26 | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1596970A CN1596970A (en) | 2005-03-23 |
| CN1302796C true CN1302796C (en) | 2007-03-07 |
Family
ID=34663544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100245221A Expired - Fee Related CN1302796C (en) | 2004-07-26 | 2004-07-26 | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1302796C (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100400086C (en) * | 2005-12-13 | 2008-07-09 | 王忠民 | Medicine for treating low function of ovary |
| CN100457177C (en) * | 2006-12-31 | 2009-02-04 | 蔡绪旺 | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney |
| CN101474348B (en) * | 2008-12-07 | 2011-12-14 | 谭逢升 | Medicament for treating infertility |
| CN101637258B (en) * | 2009-08-17 | 2012-05-23 | 北京同仁堂健康药业股份有限公司 | Health food used for improving immunity |
| CN102462696B (en) * | 2010-11-03 | 2014-10-29 | 贺毅 | Purpose of black-bone silky fowl melanin extractive in preparation of medicament for controlling depression |
| CN102008581B (en) * | 2010-12-09 | 2012-04-25 | 张跃宗 | Improved infant immunity decoction |
| CN103478536A (en) * | 2013-08-13 | 2014-01-01 | 当涂县瑞龙果树种植专业合作社 | Anti-fatigue of purple sweet potato glutinous rice flour and preparation method thereof |
| CN103444877B (en) * | 2013-09-15 | 2014-12-03 | 宁波市江东农茹生物科技有限公司 | Chickpea health-care nutrient powder with function of improving alimentary anemia |
| CN103830610B (en) * | 2014-03-19 | 2016-01-20 | 高本梅 | A kind ofly treat that women is antenatal, the Chinese medicine of puerperal constipation |
| CN105105246A (en) * | 2015-10-09 | 2015-12-02 | 张晓林 | Beverage capable of facilitating qi invigoration and blood nourishing of puerpera and preparation method thereof |
| CN108671185A (en) * | 2018-07-03 | 2018-10-19 | 谢洁如 | A kind of drug and preparation method thereof for treating chronic fatigue syndrome |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1096684A (en) * | 1993-06-16 | 1994-12-28 | 姜伟栋 | Lysium chinense and saussurea involucrata oral liquid |
-
2004
- 2004-07-26 CN CNB2004100245221A patent/CN1302796C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1096684A (en) * | 1993-06-16 | 1994-12-28 | 姜伟栋 | Lysium chinense and saussurea involucrata oral liquid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1596970A (en) | 2005-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101632827B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN1302796C (en) | Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method | |
| CN102133271B (en) | Medicinal tea for curing gout | |
| CN1966052A (en) | Tablet containing red sage root and astragalus root for removing blood stasis and preparation process thereof | |
| CN101856405B (en) | Medicinal composition for treating type II diabetes mellitus and preparation method thereof | |
| CN102671178B (en) | Preparation method of Chinese medicinal composition for treating nephrotic syndrome and uremia and application thereof | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN101953986B (en) | Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency | |
| CN1264547C (en) | Preparation of Chinese traditional medicine for treating coronary heart disease and angina as well as preparation method | |
| CN112717097A (en) | Traditional Chinese medicine composition for treating gastric cancer and preparation method thereof | |
| CN1927315A (en) | Medicine for treating psoriasis mainly and its preparation method and use | |
| CN1259078C (en) | Chinese medicine for treating women's chronic pelvic infection | |
| CN102552519A (en) | Chinese medicine composition for activating blood and stopping pain, preparation process and application | |
| CN102552520A (en) | Blood circulation-promoting and pain-stopping medicament for treating chest stuffiness and pains and preparation process and application thereof | |
| CN102205031B (en) | Traditional Chinese medicine for treating male sterility | |
| CN1943691A (en) | A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method | |
| CN101683421B (en) | Applications of traditional Chinese medicine composition in preparation of medicament for treating repetitive respiratory tract infection | |
| CN1939494A (en) | Purge capsules for old person and production thereof | |
| CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
| CN1954877A (en) | Chinese medicinal composite for treating ischemic necrosis of femoral head and its preparation method | |
| CN1158093C (en) | Medicine composition containing yak bone for treating rhenmatism and method for making same | |
| CN102284036A (en) | Gujinwan capsule and preparation method thereof | |
| CN103479868B (en) | Traditional Chinese medicine for treating apprehensive and cowardly arrhythmia and preparation method | |
| CN1410110A (en) | Application of Chinese medicine containing sarcandra for treating side effect of anticancer medicine | |
| CN100551404C (en) | Medicament for inducing diuresis to alleviate edema preparation of compositions and detection method and purposes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANDONG C.P. FREDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LING PEIXUE Effective date: 20091225 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20091225 Address after: Lunan Road, hi tech Zone, Shandong, Ji'nan Patentee after: Shandong Mingren Furuida Pharmaceutical Co.,Ltd. Address before: No. 264 mountain road, Lixia District, Shandong, Ji'nan Patentee before: Ling Peixue |
|
| C53 | Correction of patent of invention or patent application | ||
| C56 | Change in the name or address of the patentee | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ling Peixue Inventor after: Zhang Ling Inventor before: Ling Peixue Inventor before: Zhang Ling Inventor before: Qu Yanwei Inventor before: Liu Yanyan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LING PEIXUE ZHANG LING QU YANWEI LIU YANYAN TO: LING PEIXUE ZHANG LING |
|
| CP03 | Change of name, title or address |
Address after: Hi tech District Ji'nan city Shandong province 250104 Road No. 3333 Patentee after: SHANDONG MINGREN FURUIDA PHARMACEUTICAL Co.,Ltd. Address before: 250104 Lunan Road, Ji'nan hi tech Zone, Shandong Patentee before: Shandong Mingren Furuida Pharmaceutical Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070307 |